Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/24/2025

Association Between Neonatal Hypoglycemia and Metabolic Programming

Evidence for Long-Term Neurodevelopmental Impact

  • Impaired visual-motor processing is directly associated with neonatal hypoglycemia in children who experienced hypoglycemia during the neonatal period 1
  • Executive functioning deficits emerge as a consequence of neonatal hypoglycemia, affecting cognitive development trajectories 1
  • Reductions in literacy and numeracy skills in mid-childhood are linked to neonatal hypoglycemia exposure 1

Mechanism of Metabolic Programming

  • Further research is required to understand which infants are most at risk of impaired metabolic transition in the newborn period, rather than just detecting those with low blood glucose concentrations 2
  • The challenge lies in identifying who will benefit most from screening and interventions with respect to protecting long-term neurodevelopmental outcomes 2

Important Treatment Caveat

  • Rapid glucose rises following intravenous dextrose treatment may paradoxically be associated with poorer neurodevelopmental outcomes 1

Clinical Implications for Prevention

  • Prophylactic buccal dextrose gel 200 mg/kg is safe and cost-effective for reducing hypoglycemia risk in at-risk infants 2
  • However, recent follow-up data from the hPOD trial showed no significant difference in neurosensory outcomes at 2 years in at-risk infants randomized to receive prophylactic dextrose gel 2

REFERENCES